Testing effectiveness (Phase 2)UnknownNCT06427330
What this trial is testing
Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic Leukemia
Who this might be right for
Acute Lymphoid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 21